Abstract c-FLIP L expression in T cells is required for mounting effective T cell responses and can also be critical for effector T cell differentiation, as has recently been shown by a number of in vivo studies in conditional knockout and transgenic mouse systems. Available data supports therefore a novel immunomodulatory role of this anti-apoptotic protein besides its traditionally proposed function in homeostatic maintenance of T cell populations. In this study, the responses to infection with Leishmania major of mice over-expressing FLIP L specifically in the T cell compartment (TgFLIP L ) are assessed. Although previous studies have shown that FLIP L drives T cells towards a T h 2 differentiation programme in various autoimmune and allergic paradigms, in this study, we show that TgFLIP L are able to overcome this T h 2 bias in a dermal L. major infection model to mount a robust T h 1 response to pathogen and effectively clear infection. Our results suggest that vaccination protocols designed to enhance FLIP L expression in T cells may be useful for the treatment of autoimmune diseases like multiple sclerosis, without necessarily compromising immune responses towards infectious agents.
Introduction

CD4
+ T helper lymphocytes are responsible for orchestrating appropriate immune responses to a diverse array of antigens ranging from self-to pathogen-derived antigens. Following antigen encounter, naive CD4 + T cells show substantial plasticity and have the potential to differentiate towards distinct effector or regulatory cell lineages depending upon the antigen and concomitant signals from cells of the innate immune system. To date, three types of CD4 + effector T cell populations have been described, namely T h 1, T h 2 and T h 17 (1, 2) . T h 1 cells produce high levels of IFN-c and tumour necrosis factor (TNF)-a and are involved in the immunity against intracellular pathogens and autoimmunity, T h 2 cells produce IL-4, IL-5 and IL-13 and control parasitic infections and allergy and recently described T h 17 cells produce high levels of IL-17, IL-17F and IL-6 and are involved in pathogenesis of experimental autoimmune diseases. A major goal in the field of T cell differentiation is to identify the factors responsible for directing different effector T cell responses.
Specific activation signals transmitted by the TCR, co-stimulatory signals from members of the CD28 or TNF receptor families and cytokine stimuli, interplay to specify the fate of the naive T cell and to shape the resulting immune response (3). Co-stimulatory molecules, with CD28 being the best characterized, have been shown to play a critical role in the development of T h 2 effector cells (4) , particularly in the presence of weak TCR signals (5) . Several lines of evidence indicate that death receptors (DRs) of the TNF receptor family, further to their role in mediating apoptosis in activated T cells, may also modulate TCR signalling and control T cell differentiation. For example, studies in gene knockout mice have shown that the receptor adaptor Fas-associated death domain (FADD) (6) , caspase 8 (7, 8) and c-FLIP (9, 10) are essential for pathways that instruct thymocyte development and T cell maturation and effector function. In addition, the modulation of DR signalling by the over-expression of c-FLIP long isoform in T cells of transgenic mice (TgFLIP L ) resulted in diminished T h 1 profiles and the preferential expansion of the T h 2 pool in several in vivo immune paradigms including experimental autoimmune encephalomyelitis (EAE) (11) and airway hypersensitivity (12) .
Infection by the intracellular pathogen Leishmania major in mice represents a prototypic model for studying the mechanisms underlying CD4
+ T h effector cell differentiation in vivo. To further understand the role of FLIP L in shaping of T cell immunity, we tested the susceptibility of TgFLIP L (C57BL/6) mice in a dermal L. major infection model and determined their ability to mount a parasite-specific T h 1 immune response and to clear infection. Disease resolution in genetically resistant strains (e.g. C57BL/6) correlates with a higher level of activation of T h 1 cells that produce IFN-c, whereas disease progression in genetically susceptible strains (e.g. BALB/c) is associated with a more prevalent T h 2 response (13) . Overreaction of homeostatic mechanisms involving IL-10 and regulatory T cells has also been suggested to explain a non-healing form of leishmaniasis in conventionally resistant C57BL/6 mice (14) . Here, we show that TgFLIP L (C57BL/6) mice overcome inherent T h 2-biased immune responses that are apparent in models of autoimmunity and allergy and develop an adequate T h 1 effector cell response to L. major, efficiently clear infection and display memory cell formation comparable to that in wild-type (wt) mice. These results indicate that during L. major infection, the activatory signals delivered to T cells through TCR and from the innate immune environment are capable of overriding the T h 2-polarizing effects of T cell-specific FLIP L transgene expression that have been observed in other in vivo autoimmune and allergic immune paradigms.
Methods
Mice
The generation and characterization of TgFLIP L has been described previously (11) . All experiments were performed with 6-to 8-week old female mice. The transgenic mouse line was backcrossed at least 12 generations in the C57BL/6 background and in for all procedures wt littermate mice were used as controls. Mice were kept under specific pathogenfree conditions in the experimental animal unit of Hellenic Pasteur Institute. All animal procedures were approved by national authorities and conformed to the European Union guidelines for animal experimentation.
Parasites and antigens
The strain MRHO/SU/59/P of L. major (LV39) was used in all experiments. Stationary phase LV39 promastigotes were isolated by centrifugation. Promastigotes were washed three times in PBS (Flow Laboratories, Meckenheim, Germany), adjusted to 10 9 promastigotes ml À1 and disrupted by six sequential freeze-thaw cycles in order to prepare soluble promastigote lysate. Total protein determination was carried out using the Micro BCA Protein Assay Kit (Pierce, Rockford, IL, USA).
Infection with L. major
Mice received a subcutaneous (s.c.) immunization in the footpad with 2 3 10 6 stationary stage promastigotes in 40 ll volume PBS. Footpad swelling was determined thereafter at 1 week intervals by subtracting footpad thickness of the non-immunized footpad from the thickness of the L. majorimmunized footpad. Footpad thickness was determined using an electronic caliper gauge (Kori Seiki MFG Ltd, Tokyo, Japan). For secondary infection, mice received an identical challenge with L. major in the opposite footpad from the one that received the primary immunization.
In vitro T cell proliferation assays
Spleens and lymph nodes from L. major-infected mice were aseptically excised and used to prepare single-cell suspensions in RPMI-1640 supplemented with 10% foetal bovine serum (FBS), 10 mM HEPES, 50 lM 2-mercaptoethanol, 2 mM L-glutamine, 100 units ml À1 penicillin and 100 g ml À1 streptomycin (Gibco, Invitrogen Corporation, Paisley, UK). Cell viability was >95% as determined by trypan blue exclusion. Cells were cultured in triplicate in round-bottom 96-well plates (Costar, Cambridge, MA, USA) at a concentration of 1 3 10 6 cells per ml, for proliferation assays, or 24-well flat-bottom plates at 5 3 10 6 cells per ml for supernatant collection. Splenocytes were stimulated with crude soluble promastigote lysate at a concentration range of 5-20 lg ml À1 or Con A (Sigma, Munich, Germany) at a range of 2.5-10 lg ml
À1
. In lymphoproliferation experiments, cultures were incubated in 5% CO 2 at 37°C for 96 h and pulsed with 0.2 lCi ml 
Measurement of cytokine production
IL-4 and IFN-c ELISA kits (Endogen, Woburn, MA, USA) and a mouse IL-17 ELISA set (R&D Systems, Wiesbaden-Nordenstadt, Germany) were used to measure cytokine secretion from splenocyte and draining lymph node culture supernatants according to the manufacturer's instructions. The detection limit for IL-4 was 10 pg ml À1 and for IFN-c 50 pg ml
À1
. In addition, the mouse T h 1/T h 2 cytokine cytometric bead array kit (BD Biosciences, San Jose, CA, USA) was used to measure cytokine levels in culture supernatants according to the manufacturer's instructions. The sensitivity of the assay for the different cytokines is the following: IL-2, 5 pg ml
; IL-4, 5 pg ml
; IL-5, 5 pg ml
; IFN-c, 2.5 pg ml À1 and TNF-a, 6.3 pg ml
. For intracellular cytokine staining, draining lymph node cells were isolated from wt and TgFLIP L 4 weeks after footpad infection with L. major. After 3 days in culture with or without a mixture of L. major antigens (used at a concentration of 20 lg ml À1 ), cells were re-stimulated with phorbol myristate acetate (PMA)/ionomycin (Sigma) for 5 h and brefeldin A (5 lg ml À1 , Sigma) was added for the last 3 h of culture. Cells were then washed and fixed with 2% formaldehyde in PBS for 10 min at room temperature. Cells were permeabilized with 0.5% saponin in PBS/BSA/azide and stained with APC-conjugated anti-CD4 (L3T4) and PE-conjugated anti-IFN-c (XMG1.2), anti-IL-10 (JES5-16E3) and anti-IL-4 (11B11) (all antibodies were from BD PharMingen, San Jose, CA, USA). Cytometric analysis was performed using a FACSCalibur and the CellQuest software (BD Biosciences).
Infection and determination of tissue parasitism
Parasite burden was determined using a sensitive microtitration assay as published (15) . Rabbit blood agar was used to support the growth of parasites. Tissue samples were homogenized through serial passage from 21GA11/2 and 30GA1/2 needles and adjusted to 100 lg ml À1 in RPMI-1640 supplemented with 10% FBS. The number of wells positive for parasite growth was scored using an inverted microscope.
Antibody levels
Serum parasite-specific IgG antibodies and specific IgG isotypes were determined by using a standard sandwich ELISA method. Briefly, microtitre plates (Nunc Maxisorp, Roskilde, Denmark) were coated overnight with 10 lg ml À1 of a mixture of L. major antigens in 0.05 M carbonate-bicarbonate coating buffer (pH 9.6). Uncoated sites were blocked with 1% BSA in PBS. Serum samples from immunized transgenic and control littermate mice were plated and HRP-conjugated rat anti-mouse IgG1 and IgG2a mAbs (BD PharMingen) were used to detect bound antibodies. The enzyme-labelled complexes were detected by a reaction with 0.01% TMB substrate (Sigma) and 0.02% hydrogen peroxide in 0.18 M Na-acetate buffer (pH 4.0). The reaction was stopped with 2N H 2 SO 4 and optical density at 450 nm was measured using a microplate reader (Dynatech MR 5000, Dynatech Laboratories, Chantilly, VA, USA).
Statistical analysis
Data were evaluated using Student's t-test and P < 0.05 was considered significant.
Results
TgFLIP L efficiently resolve infection by L. major
TgFLIP L and non-transgenic littermate control mice, in the C57BL/6 genetic background, were inoculated with 2 3 10 6 stationary phase L. major promastigotes s.c. in one hind footpad, and subsequently monitored for lesion development by measuring the difference in thickness between injected and non-injected footpads. wt mice developed increasing swelling from the first week post-inoculation with maximum swelling observed between 6 and 10 weeks. Lesions were completely resolved by 17-18 weeks after inoculation (Fig. 1A) . TgFLIP L showed a similar clinical course with no significant difference in initiation or resolution phases and overall disease pattern, although a significant increase of swelling was seen at the peak of disease (Fig. 1A) . Measurement of tissue parasite burden using a sensitive microtitration assay showed that TgFLIP L had equivalent levels of parasite infestation as wt mice at 3 weeks after primary infection (Fig. 1B) . By 17 weeks after L. major inoculation, parasites were cleared from the site of infection, since no L. major promastigotes could be recovered from the footpad of either mouse strain (data not shown). These results show that TgFLIP L efficiently resolve infection by L. major with similar kinetics as wt mice. 25 weeks after the primary infection. Re-infection induced rapid intense footpad swelling in both groups of mice indicating the presence of an efficient and equivalent memory cellular immune response. In both groups of mice, footpad swelling reached its peak during the first week and lesions were resolved by 5 weeks after parasite inoculation (Fig. 2) . These results show that TgFLIP L mount a normal memory response to L. major infection.
Priming and recall responses of lymphocytes to L. major are normal in TgFLIP L
To analyze the immune response of TgFLIP L to L. major, TgFLIP L and wt mice were inoculated with parasite and analyzed for in vitro recall responses to a mixture of antigens prepared from L. major soluble promastigote lysate, as described in Methods. As predicted from the observation of efficient lesion resolution in TgFLIP L , splenocytes and lymph node cells showed normal proliferative responses at 3 weeks (progressive phase of infection) (Fig. 3A ) and 17 weeks (resolution phase) ( Fig. 3B and C) after infection. Moreover, memory T cell proliferation at 3 weeks after secondary challenge with parasites was also normal in TgFLIP L when compared with wt animals (Fig. 3D) . Collectively, these results demonstrate that TgFLIP L respond to L. major infection with a normal lymphocyte proliferation response which effectively limits and clears parasitic infection.
Antibody responses are normal in TgFLIP L following primary infection but show enhanced IgG1 production following secondary infection with L. major
A combination of T h 1 cell-mediated and humoral immune responses is considered important for controlling L. major infection in C57BL/6 mice. To determine whether TgFLIP L are able to develop a normal antibody immune response to L. major that is typical of the C57BL/6 strain, we measured the titers of L. major-specific IgG isotypes in sera sampled from TgFLIP L and wt mice at 3 and 17 weeks after primary infection and at 3 weeks after secondary infection (i.e. at 28 weeks) by ELISA (Fig. 4) . During the course of primary infection, both groups of mice produced statistically equivalent amounts of IgG1 and IgG2a. Upon re-infection, however, TgFLIP L produced significantly increased levels of the T h 2 priming IgG isotype IgG1 at 3 weeks after re-infection. No significant differences were detected between the groups in the production of IgG2a, the T h 1 priming antibody isotype. These results show that TgFLIP L develop a normal T h 1 response following primary and secondary infection and an enhanced T h 2-driven memory response to secondary infection.
Cytokine production following infection with L. major or in vivo priming with a mixture of parasite antigens
We next measured the levels of IFN-c produced by splenocytes isolated from TgFLIP L and wt mice after primary and secondary infection with L. major and re-stimulated in vitro with L. major antigens using a sandwich ELISA. Splenocytes from both strains showed similar expression of IFN-c at both 3 ( Fig. 5A ) and 17 (data not shown) weeks time points following primary infection. In reflection of the enhanced IgG1 antibody isotype production profiles, IFN-c production in the memory phase after re-infection with L. major showed a trend towards lower levels in the TgFLIP L (Fig. 5B ), but this difference did not reach significance levels. IL-4 production by splenocytes from both strains was undetectable at all time points studied by ELISA assay (data not shown). We also measured the production of IL-17 using an ELISA assay. IL-17 secretion was undetectable in culture supernatants of draining lymph node cells isolated from both strains of mice at 4 weeks after primary infection with parasites and re-stimulated for 3 days in vitro with L. major antigen (data not shown).
To measure the production of cytokines characteristic for T h 1/T h 2 differentiation in a primary response to L. major antigens, rather than following infection, lymph node cells were isolated from TgFLIP L and wt mice 9 days after in vivo priming with soluble L. major antigen and re-stimulated for 3 days in vitro. Cytokine secretion was measured using a bead-based flow cytometric assay in culture supernatants. TgFLIP L produced equivalent levels of IL-2 to wt mice in response to L. major antigens, and showed a trend towards decreased levels of TNF-a (Fig. 5C) and IFN-c (Fig. 5D ) production although this difference did not reach high levels of statistical significance. The production of IL-4 and IL-5 in lymph node cells from both mouse strains was below the limit of detection using this assay.
To determine cytokine production specifically by CD4 + T cells, intracellular cytokine staining was performed in draining lymph node cells that were isolated 4 weeks after infection with L. major and were ex vivo re-stimulated for 3 days with a mixture of L. major antigens. Intracellular staining of cytokines in CD4 + T cells showed that IFN-c production is not significantly different between the groups of wt and transgenic mice (Fig. 5E and F) . Low levels of IL-4 production were also detectable using this method and levels were not significantly different between mouse strains (Fig. 5E  and F) . We also measured IL-10 production in these cells since it has been described to be the cytokine responsible for immunosuppression and parasite persistence in cutaneous leishmaniasis (16) (17) (18) . TgFLIP L showed comparable IL-10 production to wt mice ( Fig. 5E and 5F ).
Discussion
Using a cutaneous L. major infection model in conventionally resistant C57BL/6 mice, we have further investigated the role of T cell-specific FLIP L transgene over-expression in the specification of T h fate. In comparison to previous findings, where down modulation of T h 1-mediated immune function and T h 2 skewing of T cell responses resulted in the suppression of myelin oligodendrocyte glycoprotein 35-55 peptide (MOG 35-55 )-induced EAE (11) and exacerbation of ovalbumin peptide-induced asthma (12), we show here that in the L. major infection model, TgFLIP L exhibited a robust T h 1 adaptive immune response to the pathogen, which is typical of the C57BL/6 strain, and cleared pathogen as effectively as normal mice. Furthermore, even though memory responses induced by secondary infection with the same parasite were characterized by reduced T h 1-polarized immunity, as indicated by significantly increased IgG1 production, mice were still able to clear re-infection normally. These observations confirm that FLIP L plays an important role in shaping T cell responses to a wide range of antigens, now including those derived from the parasite L. major, and has functional consequences in several autoimmune and allergic immune paradigms. They also suggest that during an infection, for example by L. major parasites, additional signals are delivered to T cells by the innate immune environment that overrides the otherwise T h 2-polarizing effects of T cellspecific FLIP L transgene expression.
It has become clear that apoptosis-related mediators, such as caspase 8 and FLIP L , play important roles in the control of thymocyte development and the maturation and effector function of mature T cells (6) (7) (8) (9) 19) . Inactivation of flip selectively in the T cell lineage of conditional FLIP knockout mice enhanced the sensitivity of CD4 + and CD8 + singlepositive thymocytes to TCR/CD3 and Fas-induced apoptosis resulting in severely reduced numbers of mature T cells in the periphery (9, 10) . Further, the over-expression of FLIP L in T cells of transgenic mice resulted in increased CD3-and antigen-induced proliferation (20) . We have seen that TgFLIP L (C57BL/6) T cells are capable of differentiating towards both the T h 1 and T h 2 cellular fates, but show a markedly lower production of T h 1 cytokines when compared with wt cells when stimulated ex vivo or in vitro with various peptide antigens or polyclonal activators (V. Tseveleki and L. Probert, unpublished data). As mentioned above, in vivo priming and in vitro recall stimulation of TgFLIP L T cells with a wide range of purified antigens resulted in reduced T h 1 and enhanced T h 2 cytokine responses, and in several disease paradigms, this effect translated into markedly altered clinical signs (11, 12) . The mechanism by which FLIP L alters T h differentiation is not known but biochemical studies have shown that FLIP L expression in cell lines promotes nuclear factor-kappaB and extracellular signal-regulated kinase activation (21) and inhibits c-jun N-terminal kinase activation (22) . It remains to be determined whether the T h 2 skewing effect of FLIP L in T cell pools is due to altered signalling in T cells which affects their differentiation or whether the T h 2 population is selectively protected from apoptosis leading to its aberrant expansion. Our finding, that T cell FLIP L does not lead to a T h 2 bias when mice are infected with the intracellular parasite L. major, suggests that although it might be important for physiological T cell functioning, for example for tolerance or memory formation, it might not play such a critical role during host defence reactions, where additional Fig. 5 . Measurement of IFN-c production by splenocytes isolated from TgFLIP L (grey bars, n = 3) and wt (black bars, n = 3) mice 3 weeks following primary (A) or 3 weeks following secondary (B) infection with Leishmania major, and re-stimulated ex vivo with L. major antigens, using an ELISA assay. Similar levels of IFN-c were secreted by lymphocytes of both strains of mice following primary and secondary infection. The production of T h 1/T h 2 cytokines by splenocytes isolated from TgFLIP L (grey bars, n = 3) and wt (black bars, n = 3) mice that have been immunized with a mixture of L. major antigens, and re-stimulated ex vivo with the same antigens were measured by a flow cytometric bead assay. TgFLIP L cells showed normal production of both TNF-a (C) and IFN-c (D) and levels of IL-4 and IL-5 were undetectable using this assay. Intracellular IFN-c, IL-10 and IL-4 production by CD4 + T lymphocytes was measured for PMA/ionomycin re-stimulated (E) and for 72-h L. major antigen stimulated prior to PMA/ionomycin re-stimulation (F), draining lymph node cells isolated from wt (black bars, n = 4) and TgFLIP L (grey bars, n = 4) mice 4 weeks following parasitic infection. The P values for the cytokine measurements were calculated by paired Student's t-test and were as follows: (A) P < 0.45, (B) P < 0.12, (C) P < 0.15, (D) P < 0.25(E) P > 0.05 and (F) P > 0.05.
infection-specific signals are delivered to T cells and robust T h 1 responses are required. However, we cannot exclude the alternative possibility that differences in TCR signal strength delivered by various antigens determine whether or not FLIP L can be involved in shaping T cell responses.
A major pursuit in the field of T cell biology is to apply basic knowledge to the development of improved therapeutics and vaccination strategies for the treatment of autoimmune diseases. Several of the current approaches that involve the prolonged use of immunosuppressants for the treatment of autoimmune diseases have been linked with significant adverse effects such as increased susceptibility to opportunistic infections that can be fatal (23) . For example, there are multiple Food and Drug Administration, USA (FDA) warnings associating the use of the TNF-a blocking agents with the occurrence of serious infections, including sepsis and disseminated tuberculosis. It is tempting to envision vaccination strategies that would be able to boost FLIP L expression in T cells for the treatment of autoimmune disorders without necessarily compromising host defence mechanisms to pathogens.
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